Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-019783
Filing Date
2025-07-15
Accepted
2025-07-15 19:35:20
Documents
1
Period of Report
2025-07-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3885
  Complete submission text file 0001641172-25-019783.txt   5559
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Issuer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC 100 OVERLOOK CENTER, SUITE 102 PRINCETON NJ 08540
Business Address
McNeill Lori (Reporting) CIK: 0001949324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35570 | Film No.: 251125969